Shi, Sophia M. https://orcid.org/0000-0001-6935-1034
Suh, Ryan J.
Shon, D. Judy https://orcid.org/0000-0001-8379-6195
Garcia, Francisco J.
Buff, Josephine K. https://orcid.org/0009-0005-4189-8034
Atkins, Micaiah https://orcid.org/0000-0003-0068-5217
Li, Lulin
Lu, Nannan https://orcid.org/0000-0003-0905-8199
Sun, Bryan https://orcid.org/0009-0002-0959-483X
Luo, Jian https://orcid.org/0000-0002-2064-8467
To, Ning-Sum
Cheung, Tom H. https://orcid.org/0000-0003-0796-5406
McNerney, M. Windy
Heiman, Myriam https://orcid.org/0000-0002-6365-8673
Bertozzi, Carolyn R. https://orcid.org/0000-0003-4482-2754
Wyss-Coray, Tony https://orcid.org/0000-0001-5893-0831
Article History
Received: 5 July 2023
Accepted: 3 January 2025
First Online: 26 February 2025
Change Date: 29 April 2025
Change Type: Update
Change Details: This paper was originally published under Creative Commons Attribution 4.0 International license, CC-BY-NC-ND, © The Author(s). It is now available under a Creative Commons Attribution 4.0 International license, CC-BY, © The Author(s). The error has been corrected in the online version of the article.
Competing interests
: T.W.-C. is a co-founder and scientific advisor of Alkahest Inc., a subsidiary of Grifols SA, Qinotto Inc., and Teal Omics Inc. C.R.B. is a co-founder and scientific advisory board member of Lycia Therapeutics, Palleon Pharmaceuticals, Enable Bioscience, Redwood Biosciences (a subsidiary of Catalent), OliLux Bio, Grace Science LLC, InterVenn Biosciences, Neuravid Therapeutics, GanNA Bio, Valora Therapeutics and Firefly Biologics. S.M.S., T.W.-C. and C.R.B. are co-inventors on a patent application related to the work published in this paper. The other authors declare no competing interests.